LOW vs PRME · P/E 18, rev $86.29B vs rev $3.0M
Lowe's Companies Inc (LOW) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. PRME currently screens at market cap $570.8M.
Not investment advice. Open the LOW and PRME stock pages for the full models.
Not investment advice.